Article
The base media formulation impacts the efficiency of ex-vivo erythropoiesis of primary human hematopoietic stem cells
2023-12-25
Abstract excerpt
During the COVID-19 pandemic, there was a disruption in the supply of the widely used erythroid differentiation media product, Iscove’s Modified Dulbecco’s Medium, manufactured by Biochrom AG. IMDM is a critical component of ex vivo erythropoiesis protocols used to generate genetically modified red blood cells for the study of malaria host factors. Therefore, we set out to identify the best alternative IMDM produc...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 032bc9d1-671b-5d0d-ba6d-be299ced413c
- DOI
- 10.1101/2023.12.24.573281
